Novartis (NVS) P/E (2006 - 2026)
Novartis (NVS) P/E from Mar 31, 2006 to Jul 20, 2026. The TTM Novartis (NVS) P/E is 21.42. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Novartis (NVS)
| Year | P/E | Change |
|---|---|---|
| 2026 | 21.42 | +11.20% |
| 2025 | 19.26 | +16.26% |
| 2024 | 16.57 | -39.00% |
| 2023 | 27.16 | +190.98% |
| 2022 | 9.33 | +13.68% |
| 2021 | 8.21 | -69.41% |
| 2020 | 26.84 | +43.13% |
| 2019 | 18.75 | +17.57% |
| 2018 | 15.95 | -46.55% |
| 2017 | 29.84 | +16.10% |
| 2016 | 25.70 | +117.37% |
| 2015 | 11.82 | -47.18% |
| 2014 | 22.39 | +3.10% |
| 2013 | 21.71 | +31.02% |
| 2012 | 16.57 | +23.79% |
| 2011 | 13.39 | -3.03% |
| 2010 | 13.81 | -6.49% |
| 2009 | 14.77 | +6.78% |
| 2008 | 13.83 | +30.37% |
| 2007 | 10.61 | -56.79% |
| 2006 | 24.55 | N/A |
Comparison Novartis (NVS) P/E with competitors
Novartis (NVS) P/E is 21.42.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -52.80% |
| PFE | Pfizer Inc | 11.65 | -45.59% |
| GSK | GSK Plc | 12.10 | -43.49% |
| SNY | Sanofi | 12.12 | -43.40% |
| BMY | Bristol-Myers Squibb Company | 13.82 | -35.48% |
| OGN | Organon & Company | 14.33 | -33.11% |
| BIIB | Biogen Inc | 17.41 | -18.74% |
| GILD | Gilead Sciences Inc | 17.75 | -17.15% |
| JNJ | Johnson & Johnson | 22.09 | +3.12% |
| AMGN | AMGEN Inc | 24.75 | +15.56% |
| MRK | Merck & Co Inc | 26.93 | +25.71% |
| AZN | Astrazeneca plc | 28.44 | +32.79% |
| LLY | Lilly(Eli) & Company | 48.44 | +126.17% |
| ABBV | Abbvie Inc | 139.08 | +549.33% |